689 Recruiting Trials

Clinical Trials in Arkansas

Browse 689 recruiting clinical trials currently enrolling participants in Arkansas. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 689 recruiting trials in Arkansas

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
PHASE2 Little Rock, Arkansas +4 sites · Medulloblastoma
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
PHASE2 Birmingham, Alabama +4 sites · Neuroblastoma, High-risk Neuroblastoma
Recruiting
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
N/A Little Rock, Arkansas +4 sites · Retinitis Pigmentosa, Inherited Retinal Degeneration
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
PHASE3 Phoenix, Arizona +4 sites · Low Grade Serous Ovarian Cancer
Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
PHASE3 Anchorage, Alaska +4 sites · Non-Small Cell Lung Cancer
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
PHASE1 Birmingham, Alabama +4 sites · Osteosarcoma, Neuroblastoma
Recruiting
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
PHASE3 Avondale, Arizona +4 sites · Arthritis, Psoriatic
Recruiting
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
PHASE2 Phoenix, Arizona +4 sites · CLOVES Syndrome, Klippel Trenaunay Syndrome
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
PHASE3 Birmingham, Alabama +4 sites · Depression, Major Depressive Disorder (MDD)
Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
PHASE3 Anchorage, Alaska +4 sites · Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Recruiting
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
PHASE2 Little Rock, Arkansas +4 sites · Muscle-invasive Bladder Cancer
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
PHASE2 Birmingham, Alabama +4 sites · Atopic Dermatitis, Dermatologic Disease
Recruiting
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
PHASE2 Phoenix, Arizona +4 sites · Major Depressive Disorder (MDD)
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
PHASE3 Birmingham, Alabama +4 sites · Acute Migraine
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Recruiting
See all 689 results in Arkansas

Check Your Eligibility

Create a free profile and our AI will match you to trials in Arkansas you may qualify for.

Get Matched — Free
No insurance required
Search by Condition in Arkansas
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse Other States
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon